AdvaMed speaks out on ACOs
The premise behind Accountable Care Organizations (ACOs) is solid; it’s the execution that has AdvaMed execs concerned...
Study says device review process lacking; FDA’s Shuren calls findings flawed
US patients wait on average a full two years longer than their European counterparts for many lifesaving and life-enhancing technologies made by US medical device and diagnostics companies because of growing regulatory delays and inefficiencies, according to a new study...
Study paints a grim picture of the future of medical device innovation in America: Is FDA to blame?
US patients wait on average a full two years longer than their European counterparts for many lifesaving and life-enhancing technologies made by US medical device and diagnostics companies because of growing regulatory delays and inefficiencies, according to a new study...
Evidence-based future appears certain
When it comes to healthcare reform and its impact on medical device industry, manufacturers should be prepared to “do more and spend more” on technology-oriented studies ...
Info-packed MSC Anaheim proves thought-provoking
The first-ever MSC Anaheim took place Nov 3 and 4 at the Sheraton Anaheim and attracted more than 160 industry leaders representing OEMs...
OUS strategy disturbs, or should
American expat and newly named (July 2010) CEO of Swiss-based (Morges) Biosensors International, Jeffrey Jump, oversees a company with advanced drug-eluting stents used throughout the developed world, with one notable exception: the United States...
FDA and innovations are front and center at AdvaMed 2010
Cautious optimism about the medtech business and goings-on at FDA peppered panel discussions at AdvaMed 2010 in Washington...
Taking a global approach to ethical interactions with HCPs
If it were not for the collaboration of healthcare practitioners and medical technology manufacturers, many of the life-saving and life-extending medical...
US/Japan ‘OSPREY’ seeks to streamline product approval process
The Bradenton (FL) Cardiology Center is the first center in the U.S. to implant the MISAGO Peripheral Self-expanding Stent System as part of the Occlusive/Stenotic...
Readers divided over impact of healthcare reform
Medical Design’s August/September Reader Poll question shows medical device makers and their suppliers to be split when it comes to predicting the effect healthcare reform will have on medical device and equipment innovations...
Previous | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | Next
